Sponsor:
Vancouver Infectious Diseases Centre
Code:
NCT05474781
Conditions
Hepatitis C, Chronic
Drug Use
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Interventions
Epclusa
Brief summary:
Conditions
Hepatitis C, Chronic
Drug Use
Study ID
NCT05474781
Start date
Feb 22, 2019
Status verified date
Jul, 2022
Completion date
Dec 31, 2024
Anticipated
Primary completion date
Dec 31, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Interventions
Epclusa
Primary outcome measure
Locations
Vancouver Infectious Diseases Centre
Recruiting
Vancouver, British Columbia, Canada, V6Z 2C7
Contacts
Principal Investigator:
Brian Conway, MD
Sponsor
Vancouver Infectious Diseases Centre
Last update posted
Jul 26, 2022
Last verified
Jul, 2022
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vancouver Infectious Diseases Centre on 2022-07-26.